Second Sight Medical (EYES) Reports Q4 Loss of $0.17

Second Sight Medical (NASDAQ: EYES) reported Q4 EPS of ($0.17), versus ($0.19) reported last year. Revenue for the quarter came in at $1.5 million versus the consensus estimate of $600 thousand.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M